X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4411) 4411
Book Review (338) 338
Publication (135) 135
Book Chapter (11) 11
Book / eBook (10) 10
Newspaper Article (5) 5
Conference Proceeding (3) 3
Dissertation (2) 2
Magazine Article (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3745) 3745
animals (2371) 2371
male (1931) 1931
humans (1659) 1659
rats (1422) 1422
pharmacology & pharmacy (1368) 1368
glucosides - pharmacology (1269) 1269
mice (949) 949
female (906) 906
glucosides - therapeutic use (815) 815
glucosides - administration & dosage (780) 780
rats, sprague-dawley (613) 613
glucosides (586) 586
diabetes mellitus, type 2 - drug therapy (558) 558
chemistry, medicinal (541) 541
glucosides - chemistry (528) 528
biochemistry & molecular biology (498) 498
plant sciences (485) 485
analysis (478) 478
glucose (465) 465
dose-response relationship, drug (463) 463
diabetes (451) 451
glucosides - pharmacokinetics (428) 428
middle aged (425) 425
glycosides (419) 419
oxidative stress (417) 417
type 2 diabetes (414) 414
hypoglycemic agents - therapeutic use (377) 377
adult (362) 362
sodium-glucose transporter 2 - antagonists & inhibitors (357) 357
inflammation (353) 353
rats, wistar (352) 352
administration, oral (345) 345
flavonoids (342) 342
pharmacokinetics (342) 342
apoptosis (337) 337
plant extracts - pharmacology (337) 337
food science & technology (335) 335
metabolism (329) 329
research (328) 328
endocrinology & metabolism (318) 318
rodents (301) 301
disease models, animal (299) 299
in-vitro (297) 297
glucosides - adverse effects (287) 287
dapagliflozin (283) 283
care and treatment (280) 280
benzhydryl compounds - therapeutic use (278) 278
antioxidants (270) 270
chromatography, high pressure liquid (269) 269
chemistry, analytical (268) 268
cells (265) 265
health aspects (261) 261
double-blind (260) 260
expression (259) 259
integrative & complementary medicine (256) 256
hypoglycemic agents - administration & dosage (253) 253
aged (252) 252
toxicology (251) 251
mass spectrometry (248) 248
treatment outcome (244) 244
dextrose (239) 239
glucosides - isolation & purification (239) 239
molecular structure (238) 238
glucosides - blood (235) 235
metabolites (230) 230
physiological aspects (230) 230
glucosides - metabolism (226) 226
inhibition (226) 226
plant extracts - chemistry (220) 220
activation (218) 218
diabetes mellitus (211) 211
insulin (211) 211
hypoglycemic agents - adverse effects (209) 209
phytotherapy (209) 209
blood glucose - drug effects (207) 207
sglt2 inhibitor (207) 207
blood glucose - metabolism (203) 203
apoptosis - drug effects (202) 202
hypoglycemic agents - pharmacology (200) 200
pharmacology (197) 197
cell biology (195) 195
bioavailability (194) 194
nutrition & dietetics (194) 194
benzhydryl compounds - administration & dosage (193) 193
antioxidants - pharmacology (191) 191
double-blind method (191) 191
paeoniflorin (191) 191
metformin (190) 190
mice, inbred c57bl (190) 190
chromatography, high pressure liquid - methods (189) 189
enzymes (189) 189
research article (189) 189
cells, cultured (188) 188
chemistry, applied (188) 188
antioxidant (185) 185
absorption (184) 184
liver (184) 184
biochemical research methods (183) 183
proteins (183) 183
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4279) 4279
Chinese (106) 106
German (17) 17
Japanese (14) 14
Russian (6) 6
French (4) 4
Italian (4) 4
Spanish (4) 4
Czech (3) 3
Danish (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Ethnopharmacology, ISSN 0378-8741, 09/2011, Volume 137, Issue 1, pp. 449 - 456
Journal Article
Journal Article
Diabetes care, ISSN 0149-5992, 03/2015, Volume 38, Issue 3, pp. 384 - 393
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 05/2014, Volume 16, Issue 5, pp. 467 - 477
Aim The efficacy and safety of canagliflozin, a sodium glucose co-transporter 2 inhibitor, was evaluated in patients with type 2 diabetes mellitus (T2DM)... 
thiazolidinediones | metformin | type 2 diabetes | phase 3 study | inhibitor | SGLT2 | Type 2 diabetes | Metformin | Phase 3 study | SGLT2 inhibitor | Thiazolidinediones | GLYCEMIC CONTROL | PLACEBO | ADD-ON | SULFONYLUREA | MONOTHERAPY | SITAGLIPTIN | BODY-WEIGHT | ENDOCRINOLOGY & METABOLISM | COTRANSPORTER 2 INHIBITOR | PANCREATIC-FUNCTION | Thiophenes - therapeutic use | Triazoles - administration & dosage | Thiophenes - adverse effects | Humans | Middle Aged | Pyrazines - administration & dosage | Lipids | Male | Thiophenes - administration & dosage | Genital Diseases, Female - chemically induced | Thiazolidinediones - administration & dosage | Hypoglycemic Agents - administration & dosage | Female | Glucosides - therapeutic use | Blood Pressure - drug effects | Metformin - administration & dosage | Sitagliptin Phosphate | Drug Therapy, Combination | Candidiasis - chemically induced | Glucosides - adverse effects | Hypoglycemic Agents - therapeutic use | Diuretics, Osmotic - adverse effects | Double-Blind Method | Genital Diseases, Male - chemically induced | Treatment Outcome | Blood Glucose - drug effects | Diabetes Mellitus, Type 2 - blood | Canagliflozin | Glucosides - administration & dosage | Weight Loss | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Glucose metabolism | Care and treatment | Analysis | Low density lipoproteins | Hemoglobin | Glucose | Dextrose | Drug therapy | Diabetes | Index Medicus | Original
Journal Article
Journal Article
Diabetologia, ISSN 0012-186X, 12/2013, Volume 56, Issue 12, pp. 2582 - 2592
The aim of this work was to evaluate the efficacy and safety of canagliflozin vs placebo and sitagliptin in patients with type 2 diabetes who were being... 
Sodium glucose co-transporter 2 (SGLT2) inhibitor | Medicine & Public Health | Human Physiology | Canagliflozin | Metabolic Diseases | Internal Medicine | Sitagliptin | Metformin | Type 2 diabetes mellitus | GLIPIZIDE | ADD-ON | SULFONYLUREA | DAPAGLIFLOZIN | MELLITUS | INADEQUATE GLYCEMIC CONTROL | DIET | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | 52-WEEK | INHIBITOR | Blood Pressure | Triazoles - administration & dosage | Triazoles - adverse effects | Thiophenes - adverse effects | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Pyrazines - administration & dosage | Glycated Hemoglobin A - drug effects | Body Weight - drug effects | Lipids | Male | Thiophenes - administration & dosage | Metformin - adverse effects | Hypoglycemic Agents - administration & dosage | Aged, 80 and over | Female | Metformin - administration & dosage | Sitagliptin Phosphate | Drug Therapy, Combination | Glucosides - adverse effects | Fasting | Treatment Outcome | Blood Glucose - drug effects | Diabetes Mellitus, Type 2 - blood | Glucosides - administration & dosage | Adolescent | Pyrazines - adverse effects | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Care and treatment | Body weight | Glucose | Comparative analysis | Dextrose | Index Medicus
Journal Article
Diabetes care, ISSN 0149-5992, 03/2015, Volume 38, Issue 3, pp. 355 - 364
Journal Article
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 07/2015, Volume 17, Issue 7, pp. 665 - 674
Journal Article
Journal of Pharmaceutical and Biomedical Analysis, ISSN 0731-7085, 01/2018, Volume 148, pp. 119 - 127
Journal Article
Diabetes Care, ISSN 0149-5992, 11/2015, Volume 38, Issue 11, pp. 2009 - 2017
OBJECTIVE To compare the efficacy and safety of treatment with dapagliflozin versus that with placebo add-on to saxagliptin plus metformin in patients whose... 
BODY-WEIGHT | DIPEPTIDYL PEPTIDASE-4 INHIBITOR | SULFONYLUREA | PIOGLITAZONE | EFFICACY | SAFETY | CLINICAL-TRIALS | ENDOCRINOLOGY & METABOLISM | 24-WEEK | MELLITUS | INADEQUATE GLYCEMIC CONTROL | Hypoglycemia - epidemiology | Metformin - therapeutic use | Benzhydryl Compounds - administration & dosage | Humans | Middle Aged | Male | Metformin - adverse effects | Diabetes Mellitus, Type 2 - epidemiology | Benzhydryl Compounds - adverse effects | Hypoglycemic Agents - administration & dosage | Urinary Tract Infections - chemically induced | Adamantane - therapeutic use | Adult | Female | Metformin - administration & dosage | Adamantane - administration & dosage | Hypoglycemia - chemically induced | Glucosides - adverse effects | Adamantane - adverse effects | Adamantane - analogs & derivatives | Hypoglycemic Agents - therapeutic use | Dipeptides - therapeutic use | Double-Blind Method | Dipeptides - adverse effects | Treatment Outcome | Blood Glucose - drug effects | Dipeptides - administration & dosage | Urinary Tract Infections - epidemiology | Drug Therapy, Combination - methods | Glucosides - administration & dosage | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Treatment outcome | Usage | Safety and security measures | Dapagliflozin | Analysis | Clinical trials | Dosage and administration | Metformin | Saxagliptin | Prescription drugs | Diabetes | Comparative analysis | Index Medicus
Journal Article